Clinical characteristics and serum CA19‐9 combined with HE4 are valuable in diagnosing endometriosis‐associated ovarian cancer
Ting Xu,Lin Zhang,Yi Jiang,Yicong Wan,Shulin Zhou,Guodong Sun,Wenjun Cheng,Lin Yuan
DOI: https://doi.org/10.1002/ijgo.14695
2023-01-29
Abstract:Objective Endometriosis associated ovarian cancer (EAOC) is difficult to diagnose as low incidence, uncertain risk factors, and absence of effective markers. This study aimed to investigate clinical characteristics of EAOC and identify useful serological markers. Methods We retrospectively studied clinical characteristics of 220 patients, of which 44 with EAOC and 176 with ovarian endometriosis (OEM), obtained from January 1, 2011 to October 31, 2021. Univariate and multivariate Logistic regression analyses were used to explore relationship between clinical characteristics and EAOC. Receiver operating characteristic curves were applied to access the diagnostic value of serological markers in EAOC. Results EAOC patients were older (46.20 vs. 36.26 years, P
What problem does this paper attempt to address?